Establishment and characterization of human hilar bile duct carcinoma cell line and cell strain

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 7, Issue 4, 2000, Pages 417-425

  Jiao, Wan ^a   Yakushiji, Hiroyuki ^a   Kitajima, Yoshihiko ^a   Ogawa, Akiomi ^a   Miyazaki, Kohji ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Cell line; Cell strain; Characterization; Establishment; Hilar bile duct carcinoma

Indexed keywords

HUMAN EPITHELIAL ANTIGEN 125; HUMAN EPITHELIAL ANTIGEN-125; KERATIN; MEMBRANE ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; AGED; ANIMAL; ARTICLE; BILE DUCT TUMOR; CASE REPORT; CELL CULTURE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MOUSE; MOUSE MUTANT; NUDE MOUSE; PATHOLOGY;

ADENOCARCINOMA; AGED; ANIMALS; ANTIGENS, SURFACE; BILE DUCT NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MICE; MICE, NUDE; MICE, SCID; MIDDLE AGED; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0034569510     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340070038     Document Type: Article

References (35)

1. Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics, 1996. CA Cancer J Clin 46:5-27
2. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224:463-473
3. Altaee MY, Johnson PJ, Farrant JM, Williams R (1991) Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer 68:2051-2055
4. Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH (1998) Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 228:385-394
5. Stain SC, Baer HU, Dennison AR, Blumgart LH (1992) Current management of hilar cholangiocarcinorna. Surg Gynecol Obstet 175:579-588
6. Bismuth H, Nakache R, Diamond T (1992) Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 215:31-38
7. Urego M, Flickinger JC, Carr BI (1999) Radiotherapy and multimodality management of cholangiocarcinoma. Int J Radiat Oncol Biol Phys 44:121-126
8. Takiyama I, Terashima M, Ikeda K, Kawamura H, Kashiwaba M, Tamura G, Suto T, Nakashima F, Sasaki R, Saito K (1998) Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (ICBD-1). Oncol Rep 5:463-467
9. Yamada N, Chung YS, Arimoto Y, Sawada T, Seki S, Sowa M (1995) Establishment of a new human extrahepatic bile duct carcinoma cell line (OCUCh-LM1) and experimental liver metastatic model. Br J Cancer 71:543-548
10. Knuth A, Gabbert H, Dippold W, Klein O, Sachsse W, Bitter-Suermann D, Prellwitz W, Meyer zum Buschenfelde KH (1985) Biliary adenocarcinoma. Characterization of three new human tumor cell lines. J Hepatol 1:579-596
11. Yano H, Maruiwa M, Iemura A, Mizoguchi A, Kojiro M (1992) Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC). Cancer 69:1664-1673
12. Saijyo S, Kudo T, Suzuki M, Katayose Y, Shinoda M, Muto T, Fukuhara K, Suzuki T, Matsuno S (1995) Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1. Tohoku J Exp Med 177:61-71
13. Japanese Society of Biliary Surgery (eds) (1997) General rules for surgical and pathological studies on cancer of the biliary tract, 4th edn (in Japanese). Kanehara, Tokyo, pp 2-3
14. Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ (1997) Cholangiocarcinoma: a review. Gastroenterologist 5:306-315
15. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlamyr R (1997) What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 79:26-34
16. Nimura Y, Kamiya J, Nagino M, Kanai M, Uesaka K, Kondo S, Hayakawa N (1998) Aggressive surgical treatment of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 5:52-61
17. Sirisinha S (1989) Tumor markers for early diagnosis of cholangiocarcinoma. Asian Pac J Allergy Immunol 7:1-3
18. Kannagi R (1989) Serum diagnosis of cancer with monoclonal antibodies (in Japanese). Rinsho Byori (J Clin Pathol) 82:52-86
19. Seleznick MJ (1992) Tumor markers. Prim Care 19:715-726
20. Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R (1995) Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 108:865-869
21. Chen MF (1999) Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol 14:1144-1149
22. Del Favero G, Farinati F, Di Mario F, Plebani M, Basso D, Valiante F, Meggiato T, Della Libera G, Fabris C, Fanton MC (1992) Tumor markers in gastrointestinal malignancies: an update. Eur J Cancer Prev 3:59-69
23. Fisher A, Theise ND, Min A, Mor E, Emre S, Pearl A, Schwartz ME, Miller CM, Sheiner PA (1995) CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation. Liver Transpl Surg 1:94-98
24. Peterli R, Meyer-Wyss B, Herzog U, Tondelli P (1999) CA19-9 has no value as a tumor marker in obstructive jaundice. Schweiz Med Wochenschr 129:77-79
25. Nakeeb A, Lipsett PA, Lillemoe KD, Fox-Talbot MK (1996) Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am J Surg 171:147-152
26. Ker CG, Chen JS, Lee KT, Sheen PC, Wu CC (1991) Assessment of serum and bile levels of CA19-9 and CA125 in cholangitis and bile duct carcinoma. J Gastroenterol Hepatol 6:505-508
27. Hultcrantz R, Olsson R, Danielsson A, Jarnerot G, Loof L, Ryden BO, Wahren B, Broome U (1999) A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol 30:669-673
28. Momburg F, Moldenhauer G, Hammerling GJ, Moller P (1987) Immunohistochemical study of the expression of a Mr 34000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 47:2883-2891
29. Joplin R, Hishida T, Tsubouchi H, Daikuhara Y, Ayres R, Neuberger JM, Strain AJ (1992) Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J Clin Invest 90:1284-1289
30. Crosby HA, Hubscher SG, Joplin RE, Kelly DA, Strain AJ (1998) Immunolocalization of OV-6, a putative progenitor cell marker in human fetal and diseased pediatric liver. Hepatology 28:980-985
31. Fujii H, Yang Y, Tang R, Kunitomo K, Itakura J, Mogaki M, Matsuda M, Suda K, Nobukawa B, Matsumoto Y (1999) Epithelial cell proliferation activity of the biliary ductal system with congenital biliary malformations. J Hepatobiliary Pancreat Surg 6:294-302
32. Grone HJ, Weber K, Grone E, Helmchen U, Osborn M (1987) Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am J Pathol 129:1-8
33. Mori M, Tatemoto Y, Yamamoto N, Okada Y (1988) Immunohistochemical localization of intermediate filament proteins in calcifying epithelial odontogenic tumors. J Oral Pathol 17:236-240
34. Milani S, Herbst H, Schuppan D, Niedobitek O, Kim KY, Stein H (1989) Vimentin expression of newly formed rat bile duct epithelial cells in secondary biliary fibrosis. Virchows Arch A Pathol Anat Histopathol 415:237-242
35. Klatskin G (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis: an unusual tumor with distinctive clinical and pathologic features. Am J Med 38:241-256